The Handoff: Your Week in Neurology News - 2/23/17

Follow timely coverage of the International Stroke Conference right here on Neurology Advisor.

The Handoff: Your Week in Neurology News - 2/16/17

Just days after it received FDA approval, Marathon's Emflaza is under fire from critics who claim the price of the Duchenne muscular dystrophy drug is exorbitant.

The Handoff: Your Week in Neurology News - 2/9/17

Still feeling aftershocks from its failed Alzheimer's trial, Eli Lilly announced more layoffs while Biogen faces an investigation into its payment programs for its top MS drugs.

The Handoff: Your Week in Neurology News - 2/2/17

Traumatic brain injury continues to make major headlines as a new crop of lawsuits hit the docket ahead of Super Bowl LI. Plus, are we too quick to rush to in-human trials? The authors of an op-ed in Nature think so.

The Handoff: Your Week in Neurology News - 1/26/17

One US town tries to take Big Pharma to court over the opioid crisis while the FDA continues to approve new, abuse-deterrent opioids. Plus, the first patient with refractory mesial temporal lobe epilepsy has undergone laser ablation surgery as part of the SLATE trial.

The Handoff: Your Week in Neurology News - 1/19/17

UCB Pharma looks to expand its epilepsy drug as Biogen cuts a deal to protect Tecfidera, while insiders suggest that pharmacists should play a bigger role in managing the growing Alzheimer's dementia population.

The Handoff: Your Week in Neurology News - 1/12/17

The medical community questions whether mobile stroke units are sustainable, new research further links concussions with Alzheimer's disease, and a new trial examines the effects of fasting on MS.

The Handoff: Your Week in Neurology News - 1/5/17

Happy New Year! Reflect on some of 2016's greatest neurological advances and look forward as institutions like the NIH take on a focused effort to explore new drugs for rare disease, the developing brain, and more.

The Handoff: Your Week in Neurology News - 12/22/16

The FDA has delayed the decision on ocrelizumab after manufacturing issues arise, while it gives the thumbs up to an investigational treatment for complex regional pain syndrome.

The Handoff: Your Week in Neurology News - 12/15/16

The NCAA honored the man and ALS patient behind the viral ALS Ice Bucket Challenge, while the UK approved mitochondrial replacement reproductive assistance and Bristol-Myers Squibb faces a $20 million fine for promoting off-label uses of its antipsychotic Abilify.

Sign Up for Free e-newsletters